Application 209363
- Type
- NDA
- Sponsor
- LUPIN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SOLOSEC | SECNIDAZOLE | GRANULE;ORAL | 2GM/PACKET | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 27437-051 | SOLOSEC | secnidazole | Lupin Pharmaceuticals, Inc. | NDA | Current |
| 27437-051 | SOLOSEC | secnidazole | Lupin Pharmaceuticals, Inc. | NDA | Current |
| 27437-051 | SOLOSEC | secnidazole | Lupin Pharmaceuticals, Inc. | NDA | Current |
| 27437-051 | SOLOSEC | secnidazole | Lupin Pharmaceuticals, Inc. | NDA | Current |
| 27437-051 | SOLOSEC | secnidazole | Lupin Pharmaceuticals, Inc. | NDA | Current |
| 27437-051 | SOLOSEC | secnidazole | Lupin Pharmaceuticals, Inc. | NDA | Current |
| 27437-051 | SOLOSEC | secnidazole | Lupin Pharmaceuticals, Inc. | NDA | Current |
| 27437-051 | SOLOSEC | secnidazole | Lupin Pharmaceuticals, Inc. | NDA | Current |
| 64811-401 | Solosec | SECNIDAZOLE | Ropack Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 69986 | SUPPL | 2022-01-27 |
| 69985 | SUPPL | 2022-01-27 |
| 69982 | SUPPL | 2022-01-27 |
| 69981 | SUPPL | 2022-01-27 |
| 69703 | SUPPL | 2021-12-21 |
| 69615 | SUPPL | 2021-12-17 |
| 68017 | SUPPL | 2021-07-07 |
| 68005 | SUPPL | 2021-07-01 |
| 67825 | SUPPL | 2021-06-15 |
| 67818 | SUPPL | 2021-06-15 |
| 50053 | ORIG | 2017-10-13 |
| 49751 | ORIG | 2017-09-15 |
| 49750 | ORIG | 2017-09-15 |